- Home
- TRST vs HELP Comparison
TRST vs HELP Comparison
Compare TRST & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRST | HELP |
|---|---|---|
| Founded | 1902 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.9M | 889.9M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TRST | HELP |
|---|---|---|
| Price | $54.19 | $11.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $40.06 |
| AVG Volume (30 Days) | 103.4K | ★ 1.6M |
| Earning Date | 10-20-2026 | 11-12-2026 |
| Dividend Yield | ★ 2.95% | N/A |
| EPS Growth | ★ 26.46 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $28.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.31 | $3.76 |
| 52 Week High | $59.28 | $15.15 |
Technical Indicators
Market Signals| Indicator | TRST | HELP |
|---|---|---|
| Relative Strength Index (RSI) | 33.78 | 49.77 |
| Support Level | $51.18 | $11.68 |
| Resistance Level | $56.13 | $14.75 |
| Average True Range (ATR) | 1.28 | 0.88 |
| MACD | -0.37 | -0.22 |
| Stochastic Oscillator | 7.35 | 11.44 |
Price Performance
Historical ComparisonAbout TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About HELP Cybin Inc. Common Stock
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.